Work

Preliminary Results from a Phase II Study of Response-Adapted Therapy with Copanlisib and Rituximab for Untreated Follicular Lymphoma

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-134115

Authors: Rahul Lakhotia, Christopher Melani, Jagan R. Muppidi, Stefania Pittaluga, James D. Phelan, Lydia L. Chou, Sarah Evans, Seth M. Steinberg, William D. Figg, Elaine S. Jaffe, Louis M. Staudt, Wyndham H. Wilson, Mark Roschewski

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097313477

FWCI: 0.141

Cites:

Cited by: 1

Related to: 10